eurobiological effects of sleep apnea and sleepiness

Not Applicable

Completed

• Conditions: Obstructive sleep apnea; Respiratory - Sleep apnoea

• Registration Number: ACTRN12605000089639
• Lead Sponsor: Woolcock Institute of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Obstructive sleep apnea, a comparison group of healthy subjects will also be studied.No known neurological or psychiatric diseases.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Daytime function as measured by:<br>1. symptom scales<br>2. neurocognitive performance<br>3. quantitative electroencephalography[Measured at baseline (cross-sectional component) and at 3 months (cohort substudy)]

Secondary Outcome Measures

Name	Time	Method
il.[]